Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2...

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Compa...

Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for ...

PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K...

NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Captu...

PMGC Holdings Announces Share Repurchases from Existing Shareholders...

PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nas...

Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Target...

PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance...

PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Inves...

PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above M...

Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obes...

PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acqui...

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Signs Agreement For Preclinical Mo...

PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institution...

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Pre...

PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture...

PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries...

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physicia...

PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy...